Live Update 
From the Liveblog of
Monday, August 9, 2021
From the Liveblog of
Monday, August 9, 2021
BioNTech chief: No need yet to adapt Pfizer vaccine for COVID variants
Add ToI as a Preferred Source on Google
A vial of Pfizer-Biontech COVID-19 vaccine is seen at a Clalit health clinic in Jerusalem on August 8, 2021. (Olivier Fitoussi/Flash90)
BERLIN — The first generation vaccine developed by BioNTech-Pfizer works against coronavirus variants such as the Delta strain and does not need to be modified for the moment, the chief executive of German company BioNTech says.
“It is quite possible that in the next six to 12 months, further variants will emerge and that would require adaptation of the vaccine but it is at the moment not yet the case,” Ugur Sahin tells journalists.
If you’d like to comment, join
The Times of Israel Community.
The Times of Israel Community.
JOIN THE TOI COMMUNITY
Already a member? Log in here